☰

Robert B. Abramovitch, Ph.D. - Publications

Affiliations: 
2006 Cornell University, Ithaca, NY, United States 
Area:
Plant Pathology Agriculture, Microbiology Biology
Tree Info Grants Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Martini MC, Zhang T, Williams JT, Abramovitch RB, Weathers PJ, Shell SS. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis. Journal of Ethnopharmacology. 113191. PMID 32730878 DOI: 10.1016/J.Jep.2020.113191  0.366
2020 Zheng H, Abramovitch RB. Inhibiting DosRST as a new approach to tuberculosis therapy. Future Medicinal Chemistry. PMID 32053005 DOI: 10.4155/Fmc-2019-0263  0.41
2020 Sanchez KG, Ferrell MJ, Chirakos AE, Nicholson KR, Abramovitch RB, Champion MM, Champion PA. EspM Is a Conserved Transcription Factor That Regulates Gene Expression in Response to the ESX-1 System. Mbio. 11. PMID 32019792 DOI: 10.1128/Mbio.02807-19  0.446
2019 Zheng H, Williams JT, Aleiwi B, Ellsworth E, Abramovitch RB. Inhibiting DosRST signaling by targeting response regulator DNA binding and sensor kinase heme. Acs Chemical Biology. PMID 31556993 DOI: 10.1021/Acschembio.8B00849  0.397
2019 Williams JT, Haiderer ER, Coulson GB, Conner KN, Ellsworth E, Chen C, Alvarez-Cabrera N, Li W, Jackson M, Dick T, Abramovitch RB. Identification of new MmpL3 inhibitors by untargeted and targeted mutant screens defines MmpL3 domains with differential resistance. Antimicrobial Agents and Chemotherapy. PMID 31405862 DOI: 10.1128/Aac.00547-19  0.353
2019 Baker JJ, Dechow SJ, Abramovitch RB. Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH. Trends in Microbiology. PMID 31324436 DOI: 10.1016/J.Tim.2019.06.005  0.393
2019 Jeon AB, Ackart DF, Li W, Jackson M, Melander RJ, Melander C, Abramovitch RB, Chicco AJ, Basaraba RJ, Obregón-Henao A. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain. Scientific Reports. 9: 1513. PMID 30728417 DOI: 10.1038/S41598-018-38064-7  0.39
2018 Abramovitch RB. Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development. Iubmb Life. 70: 818-825. PMID 29707888 DOI: 10.1002/Iub.1862  0.383
2018 Zheng H, Williams JT, Coulson GB, Haiderer ER, Abramovitch RB. HC2091 kills by targeting the MmpL3 mycolic acid transporter. Antimicrobial Agents and Chemotherapy. PMID 29661875 DOI: 10.1128/Aac.02459-17  0.407
2018 Baker JJ, Abramovitch RB. Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest. Scientific Reports. 8: 4168. PMID 29520087 DOI: 10.1038/S41598-018-22343-4  0.358
2017 Bosserman RE, Nguyen TT, Sanchez KG, Chirakos AE, Ferrell MJ, Thompson CR, Champion MM, Abramovitch RB, Champion PA. WhiB6 regulation of ESX-1 gene expression is controlled by a negative feedback loop in Mycobacterium marinum. Proceedings of the National Academy of Sciences of the United States of America. 114: E10772-E10781. PMID 29180415 DOI: 10.1073/Pnas.1710167114  0.349
2017 Coulson GB, Johnson BK, Zheng H, Colvin CJ, Fillinger RJ, Haiderer ER, Hammer ND, Abramovitch RB. Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics. Cell Chemical Biology. PMID 28781126 DOI: 10.1016/J.Chembiol.2017.06.018  0.365
2017 Jeon AB, Obregón-Henao A, Ackart DF, Podell BK, Belardinelli JM, Jackson M, Nguyen TV, Blackledge MS, Melander RJ, Melander C, Johnson BK, Abramovitch RB, Basaraba RJ. 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability. Plos One. 12: e0180925. PMID 28749949 DOI: 10.1371/Journal.Pone.0180925  0.411
2017 Johnson BK, Abramovitch RB. Small Molecules That Sabotage Bacterial Virulence. Trends in Pharmacological Sciences. PMID 28209403 DOI: 10.1016/J.Tips.2017.01.004  0.367
2016 Zheng H, Colvin CJ, Johnson BK, Kirchhoff PD, Wilson M, Jorgensen-Muga K, Larsen SD, Abramovitch RB. Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence. Nature Chemical Biology. PMID 27992879 DOI: 10.1038/Nchembio.2259  0.369
2016 Liu Y, Tan S, Huang L, Abramovitch RB, Rohde KH, Zimmerman MD, Chen C, Dartois V, VanderVen BC, Russell DG. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. The Journal of Experimental Medicine. PMID 27114608 DOI: 10.1084/Jem.20151248  0.721
2015 Johnson BK, Colvin CJ, Needle DB, Mba Medie F, Champion PA, Abramovitch RB. The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence. Antimicrobial Agents and Chemotherapy. 59: 4436-45. PMID 25987613 DOI: 10.1128/Aac.00719-15  0.445
2015 Johnson BK, Abramovitch RB. Macrophage infection models for Mycobacterium tuberculosis. Methods in Molecular Biology (Clifton, N.J.). 1285: 329-41. PMID 25779326 DOI: 10.1007/978-1-4939-2450-9_20  0.395
2015 VanderVen BC, Fahey RJ, Lee W, Liu Y, Abramovitch RB, Memmott C, Crowe AM, Eltis LD, Perola E, Deininger DD, Wang T, Locher CP, Russell DG. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. Plos Pathogens. 11: e1004679. PMID 25675247 DOI: 10.1371/Journal.Ppat.1004679  0.716
2014 Baker JJ, Johnson BK, Abramovitch RB. Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources. Molecular Microbiology. 94: 56-69. PMID 24975990 DOI: 10.1111/Mmi.12688  0.351
2013 Tan S, Sukumar N, Abramovitch RB, Parish T, Russell DG. Mycobacterium tuberculosis Responds to Chloride and pH as Synergistic Cues to the Immune Status of its Host Cell Plos Pathogens. 9. PMID 23592993 DOI: 10.1371/Journal.Ppat.1003282  0.741
2011 Abramovitch RB, Rohde KH, Hsu FF, Russell DG. aprABC: a Mycobacterium tuberculosis complex-specific locus that modulates pH-driven adaptation to the macrophage phagosome. Molecular Microbiology. 80: 678-94. PMID 21401735 DOI: 10.1111/J.1365-2958.2011.07601.X  0.731
2010 Russell DG, VanderVen BC, Lee W, Abramovitch RB, Kim MJ, Homolka S, Niemann S, Rohde KH. Mycobacterium tuberculosis wears what it eats. Cell Host & Microbe. 8: 68-76. PMID 20638643 DOI: 10.1016/J.Chom.2010.06.002  0.747
2009 McMullen JD, Abramovitch RB, Russell DG, Zipfel WR. Monitoring the Granulomal Micro-environment in a Monkey Model of Tuberculosis Using a Novel Fluorescence Bronchoscope Biophysical Journal. 96: 297a. DOI: 10.1016/J.Bpj.2008.12.1473  0.55
2007 Rohde KH, Abramovitch RB, Russell DG. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host & Microbe. 2: 352-64. PMID 18005756 DOI: 10.1016/J.Chom.2007.09.006  0.742
2007 Xiao F, He P, Abramovitch RB, Dawson JE, Nicholson LK, Sheen J, Martin GB. The N-terminal region of Pseudomonas type III effector AvrPtoB elicits Pto-dependent immunity and has two distinct virulence determinants. The Plant Journal : For Cell and Molecular Biology. 52: 595-614. PMID 17764515 DOI: 10.1111/J.1365-313X.2007.03259.X  0.743
2007 Rosebrock TR, Zeng L, Brady JJ, Abramovitch RB, Xiao F, Martin GB. A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity. Nature. 448: 370-4. PMID 17637671 DOI: 10.1038/Nature05966  0.702
2006 Abramovitch RB, Anderson JC, Martin GB. Bacterial elicitation and evasion of plant innate immunity Nature Reviews Molecular Cell Biology. 7: 601-611. PMID 16936700 DOI: 10.1038/Nrm1984  0.637
2006 Abramovitch RB, Janjusevic R, Stebbins CE, Martin GB. Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity. Proceedings of the National Academy of Sciences of the United States of America. 103: 2851-6. PMID 16477026 DOI: 10.1073/Pnas.0507892103  0.652
2006 Lin NC, Abramovitch RB, Kim YJ, Martin GB. Diverse AvrPtoB homologs from several Pseudomonas syringae pathovars elicit Pto-dependent resistance and have similar virulence activities. Applied and Environmental Microbiology. 72: 702-12. PMID 16391110 DOI: 10.1128/Aem.72.1.702-712.2006  0.76
2006 Janjusevic R, Abramovitch RB, Martin GB, Stebbins CE. A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase. Science (New York, N.Y.). 311: 222-6. PMID 16373536 DOI: 10.1126/Science.1120131  0.627
2005 Abramovitch RB, Martin GB. AvrPtoB: A bacterial type III effector that both elicits and suppresses programmed cell death associated with plant immunity Fems Microbiology Letters. 245: 1-8. PMID 15796972 DOI: 10.1016/J.Femsle.2005.02.025  0.637
2004 Abramovitch RB, Martin GB. Strategies used by bacterial pathogens to suppress plant defenses Current Opinion in Plant Biology. 7: 356-364. PMID 15231256 DOI: 10.1016/J.Pbi.2004.05.002  0.654
2003 Abramovitch RB, Kim YJ, Chen S, Dickman MB, Martin GB. Pseudomonas type III effector AvrPtoB induces plant disease susceptibility by inhibition of host programmed cell death. The Embo Journal. 22: 60-9. PMID 12505984 DOI: 10.1093/Emboj/Cdg006  0.691
2002 Abramovitch RB, Yang G, Kronstad JW. The ukb1 gene encodes a putative protein kinase required for bud site selection and pathogenicity in Ustilago maydis Fungal Genetics and Biology. 37: 98-108. PMID 12223194 DOI: 10.1016/S1087-1845(02)00030-0  0.401
2002 Fouts DE, Abramovitch RB, Alfano JR, Baldo AM, Buell CR, Cartinhour S, Chatterjee AK, D'Ascenzo M, Gwinn ML, Lazarowitz SG, Lin NC, Martin GB, Rehm AH, Schneider DJ, van Dijk K, et al. Genomewide identification of Pseudomonas syringae pv. tomato DC3000 promoters controlled by the HrpL alternative sigma factor. Proceedings of the National Academy of Sciences of the United States of America. 99: 2275-80. PMID 11854524 DOI: 10.1073/Pnas.032514099  0.747
Show low-probability matches.